Singapore legislation

Regulation 2

of National Registry of Diseases (Acute Myocardial Infarction Notification) Regulations 2012

Regulation 2

Definitions

In these Regulations, unless the context otherwise requires —“acute myocardial infarction” means myocardial infarction with one or more of the following:

(a)

changes in cardiac biomarkers beyond the typical limits applicable to the particular test used, together with —

(i)

symptoms indicative of myocardial ischaemia; or

(ii)

electrocardiogram changes indicative of new myocardial ischaemia;

(b)

development of new pathological Q waves in the electrocardiogram of the patient; (c)new loss of viable myocardium or new regional wall motion abnormality;

(d)

fresh thrombus,and includes acute myocardial infarction developed as a complication of cardiovascular intervention for some other cardiac condition;“patient” means a person to whom a notification referred to in regulation 3 relates.

Definition

“acute myocardial infarction” means myocardial infarction with one or more of the following:

(a)

changes in cardiac biomarkers beyond the typical limits applicable to the particular test used, together with —

(i)

symptoms indicative of myocardial ischaemia; or

(ii)

electrocardiogram changes indicative of new myocardial ischaemia;

(b)

development of new pathological Q waves in the electrocardiogram of the patient; (c)new loss of viable myocardium or new regional wall motion abnormality;

(d)

fresh thrombus,and includes acute myocardial infarction developed as a complication of cardiovascular intervention for some other cardiac condition;

Definition

“patient” means a person to whom a notification referred to in regulation 3 relates.